1. Home
  2. HON vs SNY Comparison

HON vs SNY Comparison

Compare HON & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Honeywell International Inc.

HON

Honeywell International Inc.

HOLD

Current Price

$225.90

Market Cap

141.8B

Sector

Industrials

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$46.04

Market Cap

107.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HON
SNY
Founded
1885
1994
Country
United States
France
Employees
N/A
74846
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.8B
107.3B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
HON
SNY
Price
$225.90
$46.04
Analyst Decision
Buy
Buy
Analyst Count
12
6
Target Price
$252.17
$61.50
AVG Volume (30 Days)
3.2M
3.7M
Earning Date
04-28-2026
04-23-2026
Dividend Yield
2.15%
3.54%
EPS Growth
N/A
N/A
EPS
7.36
N/A
Revenue
$36,529,000,000.00
N/A
Revenue This Year
$6.79
$3.01
Revenue Next Year
$5.81
$5.80
P/E Ratio
$30.12
$6.14
Revenue Growth
12.92
N/A
52 Week Low
$179.36
$43.32
52 Week High
$248.18
$56.00

Technical Indicators

Market Signals
Indicator
HON
SNY
Relative Strength Index (RSI) 42.26 54.90
Support Level $214.60 $45.20
Resistance Level $242.47 $48.97
Average True Range (ATR) 4.90 0.74
MACD -2.11 0.23
Stochastic Oscillator 25.70 93.47

Price Performance

Historical Comparison
HON
SNY

About HON Honeywell International Inc.

Honeywell traces its roots to 1885 with Albert Butz's firm, Butz Thermo-Electric Regulator, which produced a predecessor to the modern thermostat. Other inventions by Honeywell include biodegradable detergent and autopilot. Today, Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. It operates through four business segments: aerospace technologies, industrial automation, energy and sustainability solutions, and building automation. Recently, Honeywell has made several portfolio changes to focus on fewer end markets and align with a set of secular growth trends. The firm is working diligently to expand its installed base, deriving around one third of its revenue from recurring aftermarket services.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: